[{"address1": "930 Winter Street", "address2": "Suite M-500", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "617 443 2400", "website": "https://www.aerovatetx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aerovate Therapeutics, Inc., a biopharmaceutical company, engages in the treatment of pulmonary arterial hypertension in the United States. Aerovate Therapeutics, Inc., was incorporated in 2018 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 30, "companyOfficers": [{"maxAge": 1, "name": "Mr. Timothy P. Noyes M.B.A.", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 936899, "exercisedValue": 0, "unexercisedValue": 10446414}, {"maxAge": 1, "name": "Mr. George A. Eldridge", "age": 61, "title": "CFO & Treasurer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 658600, "exercisedValue": 0, "unexercisedValue": 1968391}, {"maxAge": 1, "name": "Dr. Benjamin T. Dake Ph.D.", "age": 48, "title": "Founder, President, COO & Secretary", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 435500, "exercisedValue": 0, "unexercisedValue": 975487}, {"maxAge": 1, "name": "Dr. Ralph W. Niven M.B.A., M.R, Ph.D., Pharm.S", "age": 64, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 372333, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hunter  Gillies M.D.", "age": 58, "title": "Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 512742, "exercisedValue": 0, "unexercisedValue": 313002}, {"maxAge": 1, "name": "Ms. Donna  Dea", "title": "Head of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susan  Fischer", "title": "Executive Vice President of Development Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen K. Yu", "title": "Senior Vice President of Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sanjeev  Khindri", "title": "Executive Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cheryl  Lassen BSc., M.D., MBBCh", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.68, "open": 2.68, "dayLow": 2.63, "dayHigh": 2.79, "regularMarketPreviousClose": 2.68, "regularMarketOpen": 2.68, "regularMarketDayLow": 2.63, "regularMarketDayHigh": 2.79, "exDividendDate": 1745539200, "payoutRatio": 0.0, "beta": 0.946, "forwardPE": -2.75, "volume": 175815, "regularMarketVolume": 175815, "averageVolume": 139077, "averageVolume10days": 316800, "averageDailyVolume10Day": 316800, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 79708752, "fiftyTwoWeekLow": 1.25, "fiftyTwoWeekHigh": 25.285, "fiftyDayAverage": 2.4994, "twoHundredDayAverage": 2.29, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1502802, "profitMargins": 0.0, "floatShares": 11964436, "sharesOutstanding": 28985000, "sharesShort": 4289371, "sharesShortPriorMonth": 4325771, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.148, "heldPercentInsiders": 0.00017000001, "heldPercentInstitutions": 1.10224, "shortRatio": 61.38, "shortPercentOfFloat": 0.3747, "impliedSharesOutstanding": 28985000, "bookValue": 2.637, "priceToBook": 1.0428517, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -69628000, "trailingEps": -2.44, "forwardEps": -1.0, "enterpriseToEbitda": -0.02, "52WeekChange": -0.8759585, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 2.75, "targetHighPrice": 3.0, "targetLowPrice": 2.0, "targetMeanPrice": 2.33333, "targetMedianPrice": 2.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 78623000, "totalCashPerShare": 2.713, "ebitda": -74314000, "totalDebt": 417000, "quickRatio": 20.539, "currentRatio": 20.929, "debtToEquity": 0.546, "returnOnAssets": -0.44883, "returnOnEquity": -0.74913, "freeCashflow": -48536500, "operatingCashflow": -71196000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "AVTE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketPrice": 2.759, "postMarketChange": 0.00900006, "regularMarketChange": 0.06999993, "regularMarketDayRange": "2.63 - 2.79", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 139077, "fiftyTwoWeekLowChange": 1.5, "fiftyTwoWeekLowChangePercent": 1.2, "fiftyTwoWeekRange": "1.25 - 25.285", "fiftyTwoWeekHighChange": -22.535, "fiftyTwoWeekHighChangePercent": -0.8912399, "fiftyTwoWeekChangePercent": -87.59585, "earningsTimestamp": 1743078600, "earningsTimestampStart": 1747080000, "earningsTimestampEnd": 1747425600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.44, "epsForward": -1.0, "epsCurrentYear": -0.355, "priceEpsCurrentYear": -7.746479, "fiftyDayAverageChange": 0.2506001, "fiftyDayAverageChangePercent": 0.10026411, "twoHundredDayAverageChange": 0.46000004, "twoHundredDayAverageChangePercent": 0.20087339, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-30", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1625059800000, "postMarketChangePercent": 0.327275, "corporateActions": [{"header": "Dividend", "message": "AVTE announced a cash dividend of 2.40 with an ex-date of Apr. 25, 2025", "meta": {"eventType": "DIVIDEND", "dateEpochMs": 1745553600000, "amount": "2.40"}}], "postMarketTime": 1744932281, "regularMarketTime": 1744920002, "exchange": "NGM", "messageBoardId": "finmb_650355034", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.6119378, "regularMarketPrice": 2.75, "marketState": "CLOSED", "shortName": "Aerovate Therapeutics, Inc.", "longName": "Aerovate Therapeutics, Inc.", "displayName": "Aerovate Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]